OM Pharma, headquartered in Switzerland (CH), is a prominent player in the biopharmaceutical industry, specialising in innovative therapies for serious diseases. Founded in 1987, the company has established a strong presence in Europe and beyond, focusing on areas such as immunology and infectious diseases. With a portfolio that includes unique biological products and advanced therapies, OM Pharma is dedicated to addressing unmet medical needs. Their commitment to research and development has led to significant milestones, including the successful launch of several key products that enhance patient outcomes. Recognised for its expertise and innovation, OM Pharma continues to strengthen its market position, contributing to advancements in healthcare and improving the lives of patients worldwide.
How does OM Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
OM Pharma's score of 18 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
OM Pharma, headquartered in Switzerland (CH), currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no documented Scope 1, 2, or 3 emissions to report. In the absence of specific emissions data, it is important to note that OM Pharma has not outlined any formal reduction targets or climate pledges. This lack of publicly available information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly prioritises sustainability, OM Pharma's future commitments to carbon emissions reduction and climate action will be crucial for aligning with industry standards and expectations.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
OM Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.